pSivida Limited, a global drug delivery company, today announced that on December 27, 2007, the Company received a letter from the NASDAQ Listing Qualifications Department notifying the Company that, for the last 30 consecutive business days, the bid price of the Company's American Depositary Shares has closed below the minimum $1.00 per share required for continued listing on the NASDAQ Global Market.
AlphaRx Inc., a leader in the development of Nanotechnology for Drug Delivery Platforms, announce that in order to meet TSX Venture Exchange listing requirements, its CEO, CFO, directors, consultants and employees plan to exercise stock options to purchase 3,300,000 shares of AlphaRx common stock.
Semiconductor Manufacturing International Corporation and International Business Machines today announced that they have signed an agreement to license IBM's 45-nanometer bulk complementary metal-oxide-semiconductor technology to SMIC for 300mm wafer foundry service.
BioAlliance Pharma SA announces that it has just received the following press release from Immtech Pharmaceuticals, Inc., the US company from which it has licensed the European rights for pafuramidine.
Xilinx, Inc. announced that it is a gold sponsor of the 21st International Conference on VLSI Design and 7th International Conference on Embedded Systems, taking place from January 4 through 8, 2008 at the Hyderabad International Convention Centre.
Arrowhead Research Corporation announced today that its President & CEO, Christopher Anzalone, will present at the 10th Annual Needham Growth Stock Conference on Wednesday, January 9, 2008 at 3:00 pm ET in New York City.
Unidym, a majority-owned subsidiary of Arrowhead Research Corp., announced that Unidym's founder, Professor George Gruner, has been selected as a visionary Technology Pioneer for 2008 by the World Economic Forum and has been invited to speak at the upcoming WEF Technology Pioneers Conference in Davos, Switzerland, this January.